super ace 88 club
Thailand-South Korea dual narrativesIowa followed its lowest-scoring game of the season with a 110-point eruption the next time out. The Hawkeyes will be one week removed from that scorching effort when they host Northwestern in Tuesday's Big Ten opener in Iowa City, but rust won't be the only roadblock for a potential repeat showing. Iowa (6-1) also is bracing for stiffer competition in conference play while navigating an injury to Seydou Traore. The reserve forward suffered a sprained ankle midway through the first half of a 110-77 home rout of South Carolina Upstate on Nov. 26. Also missing frontcourt contributors Even Brauns and Cooper Koch, the Hawkeyes still flexed their resilience and depth. Brock Harding notched a double-double of 20 points and 10 rebounds and Owen Freeman netted 17 points as five Iowa players scored in double figures. "Coming off a loss, going into Thanksgiving break here, we've got a couple days off coming, it'd be easy to kinda (think), ‘All right, let's relax for this one, guys sit out,'" Harding said. "But I think we really locked in." Northwestern (6-2) overcame 40.8 percent shooting to defeat UNLV 66-61 in the third-place game of the Arizona Tip-Off on Friday in Tempe, Ariz. Brooks Barnhizer, a preseason All-Big Ten pick who was sidelined by a foot injury during the Wildcats' first four games, had team highs of 23 points, nine rebounds and six assists. He has scored at least 20 points in three of four games. Northwestern limited UNLV to a 42.1 percent effort from the floor. Matthew Nicholson propelled the defense with two of the Wildcats' seven steals to go with two blocks. "We're a defensive-minded team and, you know, our identity is just getting stops," Barnhizer said. "Everything else will take care of itself. So, the older guys were trying to come out here and do that tonight and I think we did a pretty good job of it." Strong ‘D' helped Northwestern's ball movement, too, as the Wildcats assisted on 15 of 20 made field goals. Northwestern went 8-for-18 (44.4 percent) from long range to improve to 3-0 this season when connecting on 40 percent of its 3-point shots or better. --Field Level MediaC3.ai Stock Jumps on Earnings Report - Barron'sRupert Murdoch's audacious bid to cement his eldest son's control over one of the world's most influential media empires has failed, a US report said Monday. The first family of news -- commanding a stable that includes Fox News, The Wall Street Journal and a host of British and Australian media -- had been the inspiration for the hit TV series "Succession." Like the fictional version, this real-life fight pitted the children of a powerful patriarch against each other for who should be the face and the voice of the empire after the old man dies. Murdoch, now 93, had long intended that his children inherit the empire, and jointly decide its direction. The eldest daughter, Prudence, has had little involvement in the family business, but at various times the other three -- Lachlan, James and Elisabeth -- have all been considered as successors. But in recent years Murdoch senior had reportedly grown concerned that Fox News -- the crown jewels of the collection -- might drift away from its lucrative right-wing moorings after his death, to reflect the more centrist views of James and Elisabeth. He had therefore sought to designate Lachlan -- who currently heads Fox News and News Corp -- as the controlling player in the wider business. That had required rewriting the terms of an irrevocable trust that passed power to the four siblings jointly, stripping three of them of voting power, while allowing them to continue to benefit financially. Rupert Murdoch had argued that giving control to Lachlan -- who is understood to share his father's worldview -- was in the financial interests of the whole brood. The family intrigue played out behind closed doors in a Nevada courtroom, where Murdoch senior and his four children were understood to have given several days' evidence in September. In a decision filed at the weekend, probate commissioner Edmund J. Gorman Jr. said the father and son had acted in "bad faith" in trying to rewrite the rules, The New York Times reported, citing a copy of the sealed court document. The plan to alter the trust's structure was a "carefully crafted charade" to "permanently cement Lachlan Murdoch's executive roles." "The effort was an attempt to stack the deck in Lachlan Murdoch's favor after Rupert Murdoch's passing so that his succession would be immutable," the Times cited the ruling as saying. "The play might have worked; but an evidentiary hearing, like a showdown in a game of poker, is where gamesmanship collides with the facts and at its conclusion, all the bluffs are called and the cards lie face up. "The court, after considering the facts of this case in the light of the law, sees the cards for what they are and concludes this raw deal will not, over the signature of this probate commissioner, prevail." Murdoch's lawyer, Adam Streisand, did not immediately reply to an AFP request for comment. The ruling is not final, and must now be ratified or rejected by a district judge. That ruling could be challenged, perhaps provoking another round of legal arguments. The complicated structure of the irrevocable trust reflects the colourful familial relationships that shaped Rupert Murdoch's life as he built the multibillion-dollar empire. The trust was reported to have been the result of a deal agreed with his second wife -- mother of Lachlan, Elisabeth and James -- who wanted to ensure her offspring would not be disenfranchised by children Murdoch had with his third wife, Wendi Deng. The Murdoch empire has transformed tabloid newspapers, cable TV and satellite broadcasting over the last few decades while facing accusations of stoking populism across the English-speaking world. Brexit in Britain and the rise of Donald Trump in the United States are credited at least partly to Murdoch and his outlets. hg/nro
Steady leadership, unmatched wisdom: India’s sports community mourns Dr Singh’s demiseDPC fines Facebook owner €251m over breach
A Decade Ago, Star Wars Awakened With Its First Trailer in Years
Syrian government services come to ‘complete halt’ as workers stay at home
In the last two years, the Pune Traffic branch has levied CCTV-based and on-the-spot fines worth ₹ 154 crore on 20 lakh citizens for violation of traffic rules. Out of that amount, ₹ 57 crore has been recovered, while ₹ 97 crore is pending to be recovered by the traffic police. Traffic police had intensified their efforts to crack down on traffic violators in the city. During the past two years, using a combination of CCTV surveillance and on-ground action, the police have been identifying and fining citizens for various traffic offences. These violations include jumping red lights, exceeding the speed limits, driving without helmets, using mobile phones while driving, not wearing seatbelts, overloading, and driving in the wrong direction. According to the traffic police data, 10 lakh citizens were penalised for a cumulative fine of ₹ 77.57 crore in 2023 out of which the violators paid ₹ 32 crore and ₹ 45.17 crore is pending. In 2024 so far, 9.58 lakh citizens have faced disciplinary action, and an aggregate fine of ₹ 76.76 crore was levied, out of that ₹ 27.40 crore fine has been paid while ₹ 51.86 crore fine is yet to be recovered. The police have also been keeping a close eye on drivers who indulge in reckless driving, such as rash and negligent driving, and driving under the influence of alcohol or drugs. Additionally, the police have been focusing on drivers who violate parking rules, do not follow lane discipline, and do not give way to pedestrians or other vehicles. According to DCP (Traffic) Amol Zende, “Traffic police aim to make Pune’s roads safer for all citizens. We are using technology and manpower to identify and penalise traffic violators. We urge citizens to cooperate with us and follow traffic rules to avoid fines and ensure their safety. We will continue to take stringent action against those who put their own lives and the lives of others at risk by violating traffic rules.”Investing in the stock market requires a thorough understanding of each company’s financial health, performance history, and future prospects. But where do you start? Today, we’re looking at the best of the best with an in-depth look at five prominent TSX stocks that are currently strong buys. 1. Shopify ( ), headquartered in Ottawa, has solidified its position as a leading e-commerce platform. Enabling businesses worldwide to establish and manage online stores. In the third quarter of 2024, Shopify stock reported a 26% year-over-year revenue increase, reaching $2.16 billion, surpassing analysts’ expectations. This growth is attributed to the TSX stock’s innovative tools, including the artificial intelligence (AI)-powered assistant Sidekick, which assists merchants with sales reports and customer data analysis. Shopify’s strategic focus on attracting larger enterprises aims to secure more stable revenue streams and long-term growth. With the continuous rise of e-commerce and Shopify’s commitment to technological advancement, the TSX stock is well-positioned for sustained expansion. 2. Royal Bank of Canada As Canada’s largest , ( ) has demonstrated resilience and adaptability. In the fourth quarter of 2024, RBC reported a 17.7% increase in adjusted net income, totalling $4.44 billion. Driven by the acquisition of HSBC’s Canadian operations and strong performance in its wealth management division. The $10 billion acquisition added approximately 780,000 clients, enhancing RBC’s retail and commercial business. The wealth management division saw a significant rise in net income, reaching $969 million, aided by higher fees and recovery from previous impaired losses. RBC’s strong capital position, with a common equity tier-one (CET1) ratio of 14.9%, and a history of consistent dividend payments make it an attractive option, especially for investors seeking both growth and income. 3. Enbridge ( ) is a leading energy TSX stock in North America, operating an extensive network of pipelines and renewable energy projects. In the third quarter of 2024, Enbridge’s profit more than doubled from the previous year, reaching $1.29 billion, driven by contributions from U.S. gas acquisitions and improved organic growth opportunities. The TSX stock has forecasted higher core profits for 2025, anticipating adjusted core earnings between $19.4 billion and $20 billion, up from 2024. Enbridge’s commitment to transitioning towards greener energy solutions is evident in its investments in renewable energy assets. With a strong dividend yield and a strategic focus on energy, Enbridge offers investors a blend of income and long-term growth potential. 4. TD stock ( ) is one of Canada’s major financial institutions, offering a wide range of banking services. However, in the fourth quarter of 2024, TD reported a decline in profit. Primarily due to challenges in its U.S. operations linked to anti-money-laundering issues, resulting in a $3 billion penalty and an asset cap imposed by U.S. regulators. Despite these setbacks, TD’s diversified business model, encompassing retail banking, wealth management, and wholesale banking, provides a solid foundation. The TSX stock’s strategic expansion into the U.S. market has enhanced its growth prospects. And its commitment to digital innovation positions it well for future opportunities. 5. Bank of Nova Scotia Commonly known as Scotiabank, ( ) has a significant international presence, particularly in Latin America. In the fourth quarter of 2024, Scotiabank reported higher profits, attributed to lower provisions for potential loan losses and higher interest income. The TSX stock’s international operations offer unique growth opportunities, and its focus on digital transformation aims to enhance customer experience and operational efficiency. With a solid dividend history, Scotiabank provides a balanced mix of growth and income for investors. Bottom line Shopify, Royal Bank of Canada, Enbridge, Toronto-Dominion Bank, and Bank of Nova Scotia each present compelling investment opportunities based on their recent performance, strategic initiatives, and financial health. As always, it’s essential to conduct thorough research and consider your investment objectives before making any decisions.
Bit 3.7 Evista is a fully automated crypto trading platform that’s made to smoothen crypto trading and assist its customers in making smart trading decisions. The trading platform was developed by integrating advanced technologies and has many unique features making it a system quite different from regular trading platforms. To learn more about this trading platform, we advise that you read this review till the end. Visit Bit 3.7 Evista Platform Although Bit 3.7 Evista is a recently launched trading bot, it has garnered quite a lot of popularity in the past few weeks. This is tagged along with numerous expert assessment reports that the trading platform is trustworthy and reliable. However, it is important to check whether Bit 3.7 Evista is legitimate or not before concluding its efficiency. In this Bit 3.7 Evista review, we will be probing into the various aspects of the trading platform that can help us determine whether or not the platform is legit. So without further ado, let’s dive into the review. ● Offers live trading signals to customers ● The trading platform personalization of trading assistance ● Bit 3.7 Evista supports easy diversification of portfolio ● The trading platform is safe for all people to use ● Assures a safe trading experience ● Effortless account registration process Bit 3.7 Evista is an automated crypto trading system that’s powered by technologies like artificial intelligence, VPS systems, and algorithm tools. The trading platform monitors the crypto trading market for you 24/7 and offers you real-time data that can assist in easily identifying profitable trading opportunities. It also analyzes risk factors and helps you trade profitably by minimizing risks of loss. The crypto trading platform offers all the things you need to conduct seamless trading in one place. Bit 3.7 Evista is a user-friendly trading platform that has an intuitive website and it caters to the needs of both novice and experienced traders. The trading system allows you to trade some of the major cryptocurrencies in the market and supports quick diversification of your trading portfolio. Click Here To Try Bit 3.7 Evista For Free Bit 3.7 Evista primarily functions to ease out the whole trading process and to help you generate substantial daily profits. The trading platform offers you insights into the crypto trading market and keeps you updated on all price movements that can help in easily understanding the trading positions and exit points that will earn you profits. The trading system also analyzes risk factors for you to minimize risks. The trading system functions in two modes; they are automated and manual trading modes. In automated trading mode, the system will start trading on your behalf and will make data-driven trading decisions for you. In a manual mode of trading, the system will give you the option to autonomously trade on the platform. Based on the available data, Bit 3.7 Evista seems to be a legitimate trading platform. The trading platform’s working principle, main features, transparency, safety, customer reviews, and more suggest that the trading platform is a legitimate one and is trustworthy. However, numerous trading platforms on the internet has names and websites similar to Bit 3.7 Evista some of which claim to be variants of the original trading platform when they are not. Therefore, we recommend that you access Bit 3.7 Evista from a credible source and then create an account on its official website only. If you are interested in trading on Bit 3.7 Evista, there are a few steps that need to complete and they are the following: Register On Bit 3.7 Evista For Free Bit 3.7 Evista has many unique features that make it an efficient trading system. We will be exploring some of the main features of the system in this part. Bit 3.7 Evista is a trading bot that supports the trading of a wide range of cryptocurrencies in the market including major and minor ones. You can trade these crypto coins on the trading platform seamlessly and easily diversify your trading portfolio. Some of the main cryptocurrencies you can trade on the system include the following: Currently, Bit 3.7 Evista is legal for use in numerous countries and it’s quite popular in Asian, European, and North American continents. The list below has some of the main cryptocurrencies that support the use of the trading platform: Try Bit 3.7 Evista For Free Bit 3.7 Evista is a trading platform that does not charge you any hidden or subscription fees and it is free for all people to use. However, to begin trading on the platform, you will have to deposit capital and the minimum amount that you need to invest is $250. The capital will be used for trading purposes only. On the Bit 3.7 Evista website, multiple payment systems are available to deposit capital which includes debit/credit card payment, bank transfer, PayPal, Skrill, Neteller, and so on. Bit 3.7 Evista was studied by many experts in the crypto trading industry and they have given a rating of 4.8/5 for its efficiency. These experts meticulously analyzed the various aspects of the trading platform such as how it functions and the ways in which it supports your trading needs. According to reports shared by these experts, Bit 3.7 Evista is an efficient crypto trading platform that can enhance your overall trading experience. Besides this, customer reviews of Bit 3.7 Evista reported on various online discussion forums suggest that the trading platform is an efficient one. Customer feedback says that the trading platform has provided them with accurate and efficient analytical data that can help in making profitable trading decisions which suggests that the system is trustworthy. This Bit 3.7 Evista review analyzed the various aspects of the trading platform and we will now wrap up this review by summarizing all the things we have discussed. The trading platform was developed by integrated modern technologies such as AI and algorithm tools that examine the crypto trading market for you and offer you real-time trading data that can help in making smart trading decisions. Bit 3.7 Evista also minimizes risks and easily finds profitable trading opportunities for you. The trading platform caters to the needs of both novice and experienced crypto traders. On the trading platform, you can choose between automated and manual trading modes and the platform also allows you to personalize the assistance that you require. Bit 3.7 Evista has received positive feedback from the majority of its customers and experts who have analyzed the system have given a rating of 4.8/5. The reports shared by experts suggest that the trading system is legit and efficient. The trading system is free for all people to use and has a simple account registration process that can be completed within a few minutes. The minimum capital required to start your trading journey on the platform is only $250. So when we take these factors into consideration, Bit 3.7 Evista seems to be a beneficial trading platform that can really elevate your trading experience. Start Trading With Bit 3.7 Evista For Free How much money do I have to deposit as capital? The minimum amount of money that you have to deposit as capital is $250. How to know if Bit 3.7 Evista is supported for use in my country? You can check if Bit 3.7 Evista is supported for use in your country on its official website. What are the details that I have to share when registering accounts? The details that you have to share when registering accounts is your name, contact number, and email ID. Can I trade Bitcoin on Bit 3.7 Evista? Yes, you can trade Bitcoin on Bit 3.7 Evista. Is Bit 3.7 Evista safe to use? Bit 3.7 Evista has robust security measures that protect your safety and privacy.BOISE — Idaho’s legislative Diversity Equity and Inclusion, or DEI, work group focused on definitions, university policies and potential legislation in its second meeting. Lawmakers met Monday for a lengthy meeting that also included an overview of the 2023 U.S. Supreme Court decision that struck down race-based affirmative action and higher education accreditation standards. The committee is likely to propose legislation aimed at limiting "DEI" activities and ideology. DEI policies, activities and programs, especially in higher education, have been the target of several Republican-led states, including Idaho, in recent years. Those who advance these policies argue they promote diverse thought and support underserved populations. Opponents say these policies are "woke," and disadvantage those who are not in historically underrepresented groups. Toward the end of the meeting, committee member Sen. Ben Toews, R-Coeur d'Alene, commented that the task force ultimately wanted to prohibit actions that were “punishing diversity of thought that is outside this ideology.” As an example, he said as a student he took a Christian doctrine class that was cross-listed as a Women’s Studies class. “I came in with my own experience, my own personal beliefs, and through the process of expressing beliefs, I had the professor from the class say that I’m stuck in the ‘50s, accusing me of bigotry, and these are exactly the concerns that we’re trying to deal with.” One of the targets of debate Monday, both in discussions over a draft resolution from the State Board of Education and around a bill in Utah prohibiting DEI, were centers at universities meant to support certain students — such as women’s centers. “It’s really saying that our centers are going to focus on support for students,” Idaho State Board of Education Executive Director Joshua Whitworth told the work group regarding some of the draft, anti-DEI resolutions the board is considering. Joshua Whitworth The lone Democrat on the legislative committee, Senate Minority Leader Melissa Wintrow, Boise, worked in higher education and served as director of Boise State University's Women’s Center. Wintrow questioned this proposed policy, asking if these centers were currently denying students who aren't the target for services — such as men seeking help at the women's center. Wintrow said in her tenure as director, there were male students who came to the center to report and seek services for rape, and she provided those services. She also said that there were situations where the center’s name could be beneficial to those who seeking services. Wintrow told the story of a woman in an abusive marriage who drove her husband to class every day and saw the sign of the old Women’s Center. The woman eventually decided to go in and seek help. “Thankfully, she did escape, and she’s doing well today,” Wintrow said. “But if it hadn’t been for that sign, Women’s Center, that she drove by repeatedly, to get the courage to come in and find help, I don’t know where she’d be today.” BSU later changed the name to Gender Equity Center, but the webpage for the Gender Equity Center no longer appears on the university’s website, a search Monday found. These types of student support centers also came up in a discussion overviewing Utah’s anti-DEI bill that its legislature passed this year. Toews provided a short overview of the 35-page bill that included a section requiring universities and colleges’ student success and support centers to serve all students. The law also prohibits higher education institutions from using public funds for training or activities that prioritize certain racial, ethnic or gender groups, Toews said. The senator, who later said he had drafted legislation that would accomplish similar goals to other anti-DEI bills, said he thought Utah’s legislation included a useful definition for Idaho when considering a future bill. The law includes a long description of a “prohibited discriminatory practice,” which would include a policy, procedure, program, office, initiative or training that “asserts that one personal identity characteristic is inherently superior or inferior to another personal identity characteristic” and “asserts that an individual, by virtue of the individuals’ personal identity characteristics, is inherently privileged, oppressed, racist, sexist, oppressive, or a victim, whether consciously or unconsciously.” Sen. Melissa Wintrow answers questions from members of the media during a press event in the Lincoln Auditorium on March 7, 2024. The definition also includes that the prohibited practice, “asserts that an individual should feel discomfort, guilt, anguish, or other psychological distress solely because of the individual's personal identity characteristics,” that “meritocracy is inherently sexist or racist,” that “socio-political structures are inherently a series of power relationships and struggles among racial groups,” and that considers race or gender for financial aid and scholarships. Toews noted that the survey and reporting requirements under Utah’s bill won’t return results until 2027 in regards to how it impacted students and faculty. “I think that’s a weakness in following suit with Utah,” he said. “My belief is that we should be looking at best practices developed by other states that have these laws in effect for a longer period of time, such as Iowa, who enacted those in 2021, and Texas, who enacted theirs in 2023. The definition portion of Utah is the best I’ve seen so I’m suggesting incorporating that into any bills we recommend in Idaho, and even improving on it if possible.” A staff report, presented by Legislative Services Office Research Analyst Casey Hartwig, found few definitions of “DEI as a concept,” but more commonly saw the terms diversity, equity and inclusion defined individually. The lawmakers also heard and questioned leaders at the regional higher education accreditor, the Northwest Commission on Colleges and Universities (NWCCU), which accredits all of Idaho’s public colleges and universities as well as some of the state’s private institutions. NWCCU President Sonny Ramaswamy and Executive Vice President Selena Grace spoke to how the organization applies its standards to accredit schools. Colleges and universities may seek accreditation voluntarily but are required to do so to be eligible for federal funds. The short answer to questions about whether its standards and requirements would prompt DEI concerns was “no.” Grace and Ramaswamy stressed that each school is evaluated based on its own goals and those goals are not imposed upon schools by the accreditor. Sonny Ramaswamy “There isn’t anything, a requirement for us or by us, related to DEI,” Grace said. There are more recent requirements for schools to collect and provide data on achievement gaps within their student populations. Nationwide, these gaps are significant between first-generation college students and their peers with parents who hold degrees, as well as between students who qualify for low-income Pell Grants and those who don’t, Ramaswamy said. Another achievement gap is between men and women in colleges, with more women entering higher education and women graduating at a much higher rate, he said. Toews questioned Ramaswamy on the fact that “diversity, equity and inclusion” is included in the accreditor’s core values on its website, which states, ”We believe there is strength in our differences and that opportunities to succeed are afforded every individual.” Ramaswamy said the core values relate to how NWCCU operates as an organization, not to how it evaluates schools. “Those are core values for us, the commission staff, how we operate, that we got to respect those missions,” he said. Rep. Dale Hawkins, R-Fernwood, asked Ramaswamy if he personally believed institutions would benefit from diversity, equity and inclusion. “I use data and evidence,” Ramaswamy responded, after the question was asked a couple of times. “I don’t use beliefs.” The group is likely to meet again the first week of the legislative session, which begins Jan. 6.
Matt Gaetz says he won’t return to Congress next year after withdrawing name for attorney generalThunderstorms, humid conditions to continue across the Hunter | live updates
Hyperconnected employees experiencing ‘dark side’ of digital workTHOUSAND OAKS, Calif. , Dec. 2, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2024 Global Healthcare Conference at 9:30 a.m. ET on Thursday , Dec. 5, 2024. Peter Griffith , executive vice president and chief financial officer at Amgen, Jay Bradner , executive vice president of Research and Development and chief scientific officer at Amgen, and Susan Sweeney , executive vice president of Obesity and Related Conditions at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME. For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn , Instagram , TikTok , YouTube and Threads . Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla ® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2024-global-healthcare-conference-302319891.html SOURCE AmgenNo. 22 Xavier faces South Carolina St., eyes rebound from lone loss
Editorial: For Joe Biden, Hunter and personal pique trumped the rule of law